Clearance? Approval? What Should Investors Make of Nano-X's FDA Decision?

·3-min read

Last month, Nano-X Imaging (NASDAQ: NNOX) gained 501(k) clearance from the Food and Drug Administration (FDA) for its X-ray device. In this video from Motley Fool Live, recorded on April 5, contributors Brian Orelli and Keith Speights discuss the difference between an FDA clearance and approval and what the results could mean for the medical-device maker. Brian Orelli: We have a couple of questions on Nano-X Imaging.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting